Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eurythmy Therapy (ERYT) as a Treatment Option for Fatigue in Metastatic Breast Cancer Patients

NCT04024267 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT04024267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04024267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eurythmy Therapy (ERYT) as a Treatment Option for Fatigue in Metastatic Breast Cancer Patients
Lead sponsor
University of Bern
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2020
Completion date
July 31, 2025
Enrollment
19 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, fatigue